Genomics Market Soars
Analysts project the global genomics market will reach USD 85.09 billion by 2030, driven by NGS, AI bioinformatics, and precision medicine—signaling rising demand for cytologists with molecular and data skills. The forecast underscores why labs are expanding genomics workflows. (globenewswire.com)
MarketsandMarkets lists a compound annual growth rate of 12.6% for the genomics market over 2025–2030 and reports the market increased from US$44.52 billion in 2024 to US$47.07 billion in 2025. (MarketsandMarkets.com (marketsandmarkets.com)) The publisher’s report for the sector is described as 560 pages with 671 market tables and figures, indicating detailed breakdowns by product, service, technology, study type, application and geography. (MarketsandMarkets.com (marketsandmarkets.com)) By offering, the products segment (reagents, kits and consumables; instruments and systems) accounted for roughly three-quarters of the market in 2024, with reagents/kits/consumables identified as the largest subsegment. (MarketsandMarkets Blog (marketsandmarketsblog.com)) MarketsandMarkets names leading vendors including Illumina, Thermo Fisher Scientific, Danaher, Roche, QIAGEN, Agilent and Oxford Nanopore as major market players, and notes these firms collectively account for an estimated 40–50% share of the global genomics market. (MarketsandMarkets.com (marketsandmarkets.com)) Geographic splits in the report show North America held the largest share at about 40.9% in 2024, while the Asia‑Pacific region is projected to register the fastest regional growth through the forecast period. (MarketsandMarkets Blog / PR Newswire (marketsandmarketsblog.com) (prnewswire.com)) The report’s taxonomy lists study‑type segments—functional genomics, biomarker discovery, pathway analysis and epigenomics—and application buckets including drug discovery, diagnostics and agriculture, signaling where vendor product lines and clinical lab services are mapped in the dataset. (MarketsandMarkets.com (marketsandmarkets.com))
